drugset / Trial / NCT04420234
A Pharmacokinetics and Safety Study of Narfurine Hydrochloride Orally Disintegrating Tablets
Phase 1
Unknown
30 enrolled
First Affiliated Hospital of Zhejiang University
Shenyang Sunshine Pharmaceutical Co., LTD. · collab
NaSingle-groupOpen-labelTreatment
Summary
Main objective: To evaluate the pharmacokinetics of single and multiple oral administration of narfurine hydrochloride orally disintegrating tablets in Chinese healthy adult subjects. Secondary objective: To evaluate the safety profile of single and multiple oral administration of narfurine hydrochloride orally disintegrating tablets in Chinese healthy adult subjects.
Timeline
- Start
- 2020-06-09
- Primary completion
- 2020-07-28
- Completion
- 2020-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | narfurine | Unknown | 5 ug | Oral |
Indications
No indication recorded.